S89.322S Salter-Harris Type II physeal fracture of lower end of left fibula, sequela

Name of the Condition

• Salter-Harris Type II physeal fracture of lower end of left fibula, sequela

Summary

A Salter-Harris Type II physeal fracture of the lower end of the left fibula, sequela, refers to the residual effects of a previous growth plate fracture at the distal fibula. This condition occurs after the initial injury has healed, and the term "sequela" indicates ongoing consequences such as chronic pain, deformity, or functional limitations. The fracture involves a separation through the growth plate with a metaphyseal fragment, and the sequela may result from incomplete healing, growth disturbance, or long-term joint instability.

Causes

The sequela arises from a prior Salter-Harris Type II physeal fracture of the distal left fibula, typically caused by trauma such as falls, sports injuries, or accidents involving shear or tensile forces on the ankle. Incomplete healing, malunion, or growth plate damage during the initial injury can lead to persistent symptoms or structural changes, resulting in the sequela.

Risk Factors

• Age: Occurs in individuals who sustained the initial fracture during childhood or adolescence, when growth plates are still open.
• Initial Injury Severity: More severe or displaced fractures increase the risk of long-term complications.
• Delayed or Inadequate Treatment: Improper management of the original fracture may contribute to residual issues.

Symptoms

• Chronic pain or discomfort around the ankle or distal fibula.
• Persistent swelling or stiffness in the affected area.
• Difficulty bearing weight or reduced mobility in the left leg.
• Possible visible deformity or limb length discrepancy.

Diagnosis

Diagnosis involves a clinical evaluation of the patient's history, including the initial fracture and subsequent recovery. Physical examination assesses for tenderness, deformity, or functional limitations. Imaging studies, such as X-rays or MRI, may be used to evaluate residual bone changes, joint alignment, or growth plate abnormalities. The presence of sequela is confirmed by correlating current symptoms with the prior injury.

Treatment Options

Treatment focuses on managing symptoms and improving function. Options may include physical therapy to strengthen surrounding muscles and improve mobility, pain management with medications or injections, and orthotic devices to support the ankle. In severe cases, surgical intervention may be considered to correct deformities or stabilize the joint.

Prognosis and Follow-Up

Prognosis depends on the extent of the initial injury and the effectiveness of treatment. Many patients experience improved function with conservative management, though some may have persistent limitations. Regular follow-up with a healthcare provider is important to monitor for complications and adjust treatment as needed.

Complications

• Chronic pain or arthritis in the ankle joint.
• Growth disturbances leading to limb length discrepancy.
• Reduced range of motion or instability in the left ankle.
• Increased risk of future fractures in the affected area.

Lifestyle & Prevention

• Avoid high-impact activities that stress the ankle until cleared by a healthcare provider.
• Use appropriate footwear and protective gear during sports or physical activities.
• Maintain a healthy weight to reduce joint stress.
• Follow rehabilitation guidelines to restore strength and mobility after injury.

When to Seek Professional Help

Seek medical attention if you experience worsening pain, new swelling, or difficulty bearing weight on the left leg. Consult a healthcare provider if chronic symptoms interfere with daily activities or if you notice changes in limb alignment or function.

Tips for Medical Coders

This code is used for the sequela of a Salter-Harris Type II physeal fracture of the lower end of the left fibula. Documentation should clearly indicate the prior fracture and the residual effects, such as chronic pain, deformity, or functional impairment. Ensure the code aligns with the patient's current clinical status and the nature of the sequela.